Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Clear all

122 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20027
20031
20043
20056
20064
20075
20088
20093
20108
20115
20122
20133
20144
20152
20163
20174
20187
20195
20203
20214
20222
20237
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated20
Active, not recruiting12
Unknown status8
Recruiting5
Withdrawn3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene7
European Organisation for Research and Treatment of Cancer - EORTC6
M.D. Anderson Cancer Center4
Novartis Pharmaceuticals4
Alliance for Clinical Trials in Oncology3
Astex Pharmaceuticals, Inc.3
Children's Oncology Group3
Medical College of Wisconsin3
St. Jude Children's Research Hospital3
Takeda3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes122
Leukemia, Myeloid, Acute55
Leukemia39
Precursor Cell Lymphoblastic Leukemia-Lymphoma31
Leukemia, Myelomonocytic, Chronic29
Myeloproliferative Disorders26
Lymphoma23
Anemia, Refractory, with Excess of Blasts18
Lymphoma, Non-Hodgkin18
Anemia17

Trials

Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.

22 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.